Issue 2: January 2018   Our Mission The ICRN is a global collaboration of research groups from renowned institutions that are working in concert to improve knowledge about cholangiocarcinoma etiology, prevention, early detection, treatment and prognosis. The network is comprised of highly talented individuals from a spectrum of disciplines, perspectives, and research methods who share the passion to make significant scientific advances that improve outcomes for patients with cholangiocarcinoma. ICRN Participating Centers U.S. Centers Banner Health Emory University Fred Hutchinson Cancer Research Center Johns Hopkins University Massachusetts General Hospital  Mayo Clinic MD Anderson Cancer Center Memorial Sloan Kettering Cancer Center Moffitt Cancer Center University California San Francisco University of Michigan University of Utah Vanderbilt University Virginia Mason Medical Center Yale University International Centers Chulalongkorn University [Thailand] National Health Research Institutes, Kaoshsiung Medicine University [Taiwan] Pusan National Hospital Siriraj Hospital [Thailand] University College London Hospital [UK] University of Amsterdam [Netherlands] University of Calgary [Canada] University of Nottingham [UK] We would like to welcome our newest ICRN participating centers Christie NHS Foundation Trust Cleveland Clinic Foundation Hacettepe University cancer Institute [Turkey] Hepatobiliary Medical Society Returned Scholar Association [China] Peking Union Medical College Hospital [China] Princess Margaret Hospital [Canada] University of Southern California University of Washington ICRN Working Groups The ICRN Working Groups help us to better coordinate our research efforts. Leadership: Dr. Milind Javle and Dr. Mitesh Borad provide overall direction of the ICRN including clinical trials, Industry Forum, Asia-Pacific Conference, and publications. Surgical: Dr. Yun Shin Chun and Dr. Flavio Rocha spearhead efforts in surgical translational research. Clinical Research: Dr. Laura Goff leads the clinical data sharing for collaborative research. Genomic Research: Dr. Lipika Goyal leads genomic research initiatives. International collaboration: Dr. John Bridgewater and Dr. Virote Sriuranpong recruit Asian, European and other international centers for collaborative research. Biorepository: Dr. Lewis Roberts and Dr. Milind Javle coordinate the ICRN tissue and blood banking repository. Administration: Dr. Reham Abdel-Wahab and Donna Mayer provide oversight of budgets, grants, meetings, ICRN website and newsletters. We welcome your participation in the Working Groups of your choice. Email Dr. Reham Abdel-Wahab at raali@mdanderson.org for more information. ICRN Executive Committee Chair: Milind Javle, MD Gastrointestinal Medical Oncology Department MD Anderson Cancer Center Reham Abdel-Wahab, MD, PhD ICRN Associate Program Director Melinda Bachini Advocacy Director Cholangiocarcinoma Foundation Dr. John Bridgewater, MRCP, PhD Medical Oncology Department University College London Hospitals Yun Shin Chun, MD, FACS Surgical Oncology Department MD Anderson Cancer Center   Laura Goff, MD Hematology/Oncology Department Vanderbilt Ingram Cancer Center   Lipika Goyal, MD Hematology/Oncology Department Massachusetts General Hospital Shishir K. Maithel, MD, FACS Department of Surgery Emory University School of Medicine Vice-Chair: Mitesh Borad, MD Medical Oncology Department Mayo Clinic   Donna Mayer ICRN Program Director Cholangiocarcinoma Foundation Stacie Lindsey President and Founder, Cholangiocarcinoma Foundation Judith McBrien Patient Advocate Cholangiocarcinoma Foundation Flavio G. Rocha, MD, FACS Hepatopancreatobiliary Service Virginia Mason Medical Center   Lewis Roberts, MB, ChB, PhD Division of Gastroenterology and Hepatology, Department of Internal Medicine, Mayo Clinic   Virote Sriuranpong, MD, PhD Medical Oncology Department Chulalongkorn University Dr. Shishir K. Maithel We would like to welcome our newest ICRN Executive Committee Member - Dr. Shishir K. Maithel, MD, FACS. He is an Associate Professor of Surgery in the Division of Surgical Oncology, Department of Surgery at Emory University School of Medicine. As Scientific Director of the Emory Liver and Pancreas Center, he leads the clinical / translational research program in the Division of Surgical Oncology, which focuses on identifying tumor specific molecular biomarkers as predictors of outcome and chemotherapeutic response for hepatobiliary tumors. Dr. Maithel is also Director and National Principal Investigator of the U.S. Extrahepatic Biliary Malignancy Consortium, and is an active member and study lead in the Central Pancreas Consortium. Save the Date We welcome your participation in these important meetings. ICRN Member Meeting at GI ASCO Friday, January 19 6:45-7:45am InterContinental Hotel - Telegraph Room 888 Howard Street, San Francisco Click here to RSVP 5th Cholangiocarcinoma Foundation Annual Conference January 31-February 2 Marriott at City Creek, Salt Lake City, Utah Visit the Conference Website ICRN Meeting Thursday, February 1 7:00-8:00am Cottonwood Room, 1st Floor ICRN Industry Forum(s) Thursday, February 1 and Friday, February 2 12:00-2:00pm Brighton Room, 2nd Floor Click here to RSVP 2nd Asia-Pacific Congress March 23-24, 2018 Siriraj University Hospital, Bangkok Chaired by Mitesh Borad, MD(Mayo Clinic) and Charuwan Akewanlop, MD (Siriraj Hospital, Thailand) Visit the Conference Website ©2006-2017 All Rights Reserved, The Cholangiocarcinoma Foundation 5526 West 13400 South, #510, Herriman, Utah 84096, U.S.A. (888) 936-6731 icrn@cholangiocarcinoma.org